Short versus long course radiation after breast-conserving surgery
Part of Cancer, Skin clinical trials.
This trial compares a one-week radiation treatment to a three-week treatment for early-stage breast cancer. It aims to see if the shorter course is as effective and safe, potentially making treatment more convenient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman expected to live more than 5 more years.
- You have early-stage breast cancer (either invasive or DCIS) treated with surgery that removed the tumor but kept your breast.
- For invasive cancer: you are 40 to 75 years old, your tumor was 3 cm or smaller, and it was hormone receptor positive.
- For DCIS (non-invasive cancer): you are 18 to 75, your tumor was 2.5 cm or smaller, and it was low or intermediate grade.
- No prior radiation to the same breast or chest, no active second cancer, and you are not pregnant.
- You are generally fit (able to perform daily activities) and can tolerate lying still during radiation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether radiation therapy alone is safe and effective for women 40 and older with early-stage breast cancer who have not had lymph node sampling. It aims to simplify treatment while maintaining good outcomes.
This trial compares a shorter course of radiation (fewer, larger doses) with the standard longer course for women who have had breast cancer surgery with implant-based reconstruction. It aims to see if the shorter schedule is just as safe and effective for the chest area, while being more convenient.
This trial compares giving breast radiation over one week versus three weeks after surgery. It aims to see whether the shorter schedule works just as well and is safe for people with certain types of early breast cancer.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial compares a shorter, one-week course of radiation to the standard two-week course after a lumpectomy for early-stage breast cancer. The goal is to see if one week is just as effective and safe, making treatment more convenient.
This trial compares two types of partial breast radiation: one session versus several shorter sessions. It aims to see if a single treatment is as effective and more convenient for women with early-stage breast cancer.
Hear when a new Early-stage Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.